United Cannabis Corporation Registration Statement Declared Effective By SEC
May 10 2017 - 12:55PM
Access Wire
S-1 Registers 5 Million Shares of UCANN Common Stock
in Conjunction with $10 Million Commitment by Tangiers
Global
DENVER, CO / ACCESSWIRE / May 10, 2017 / United
Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United
Cannabis"), the creator of Prana Bio Nutrient Medicinals, today
announced that its S-1 registration statement (the "Prospectus")
was declared effective by the U.S. Securities and Exchange
Commission ("SEC").
The Prospectus covers the resale of United Cannabis' common
stock in connection with the Company's December 2016 Investment
Agreement (the "Agreement") with Tangiers Global, LLC ("Tangiers").
Under the terms of the Agreement, Tangiers has committed to
purchase up to $10 million in shares of the Company's common stock,
at a 15% discount to the market price.
This release does not constitute an offer to sell, nor is it a
solicitation of an offer to buy the Company's securities, which may
only be made by means of a prospectus. The full registration
statement can be viewed at the SEC website:
https://www.sec.gov/Archives/edgar/data/1436161/000155335017000425/cnab_s1.htm
About United Cannabis Corporation
United Cannabis Corporation is a biotechnology company dedicated
to the development of phyto-therapeutic based products supported by
patented technologies for the pharmaceutical, medical, and
industrial markets. The Company is a pioneer in the application of
cannabinoids for medical applications and is building a platform
for designing targeted therapies to increase the quality of life
for patients around the world. The Company's products are patent
protected, first in class medicines with applications to a global
market. United Cannabis trades on the OTCQB under the symbol
CNAB.
For further information, please visit www.unitedcannabis.us.
Contact: Staff@UnitedCannabis.us
Phone: 303-386-7321
SOURCE: United Cannabis Corporation